DNAJC5 and malaria: Follow-up studies that explore the mechanisms by which Fc-engineered CSP mAbs engage in innate and adaptive immunity and thereby increase potency have the potential to support the development of anti-malarial therapeutic antibodies with enhanced efficacy and practicality for deployment in resource-limited malaria-endemic regions.